Hussman Strategic Advisors, Inc. Illumina, Inc. Transaction History

Hussman Strategic Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$92.79 - $142.53 $584,577 - $897,939	-6,300 Reduced 37.5%	10,500 $1.46 Million
Q3 2023 Nov 07, 2023	BUY	$128.91 - $192.44 $554,313 - $827,492	4,300 Added 34.4%	16,800 $2.31 Million
Q2 2023 Aug 03, 2023	BUY	$183.43 - $232.67 $1.16 Million - $1.47 Million	6,300 Added 101.61%	12,500 $2.34 Million
Q1 2023 May 04, 2023	SELL	$193.75 - $232.55 $310,000 - $372,080	-1,600 Reduced 20.51%	6,200 $1.44 Million
Q4 2022 Feb 08, 2023	SELL	$187.24 - $242.74 $861,304 - $1.12 Million	-4,600 Reduced 37.1%	7,800 $1.58 Million
Q3 2022 Nov 02, 2022	BUY	$177.23 - $227.44 $815,258 - $1.05 Million	4,600 Added 58.97%	12,400 $2.37 Million
Q2 2022 Sep 12, 2022	BUY	$181.58 - $368.0 $1.42 Million - $2.87 Million	7,800 New	7,800 $1.44 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.